Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/462911

Characterization of oral microbiota in marmosets: feasibility of using the marmoset as a human oral disease model

Takehara, S.·Zeredo, J.·Kumei, Y.·Kagiyama, K.·Fukasawa, K.·Oshiro, A.·Ueno, M.·Minakuchi, S.·Kawaguchi, Y.
View original source ↗Export metadata ↓

Abstract

As the worlds population is aging, there is an increasing demand for research regarding aging and aging-related disorders, to achieve better understanding of aging. Ideally, such research would be performed with human subjects. However, due to ethical considerations, animals such as rodents and monkeys are used as alternatives. Among these alternative models, non-human primates are preferred because they share common traits with humans. The small South American common marmoset (Callithrix jacchus) may offer a number of advantages over other non-human primates in terms of its relatively small size, short life span, and identical dental anatomy, compared with humans. The purpose of this study was to clarify the viability of using the marmoset as a human oral disease model.\n\nWe collected saliva samples from eight common marmosets and eight human subjects. Prokaryotic DNA was extracted from the saliva samples, and 16S bacterial rRNA gene sequencing was performed on each of the samples. Our results indicated that the types of oral microbiomes detected among human and marmoset samples were nearly identical. In contrast, the oral microbiomes of our human and marmoset subjects were distinctly different from those of rat and dogs, which are popular animal models. The oral microbiomes of marmosets showed greater diversity than those of humans. With respect to individual variation, marmosets exhibited less variation in their oral flora, compared with humans. This difference in variation might be attributed to the fact that marmoset subjects were kept in a controlled environment with identical lifestyles.\n\nThe characteristics of its oral microbiota, combined with other technical advantages, suggest that the marmoset may provide the best animal model thus far for the study of oral health. This study characterized the oral microbes of the marmoset, thereby providing information to support future application of the marmoset as a model for age-related oral disease.

Source connections

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Takehara, S., Zeredo, J., Kumei, Y., Kagiyama, K., Fukasawa, K., Oshiro, A., Ueno, M., Minakuchi, S., Kawaguchi, Y.. 2018-11-05. Characterization of oral microbiota in marmosets: feasibility of using the marmoset as a human oral disease model. https://doi.org/10.1101/462911

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Cell-scale confinement reorders bacterial speed rankings

Which bacterium swims fastest depends on where the race is run. Speeds are usually measured in open liquid, yet many bacteria live in pores, mucus and host passages no wider than a cell. Using a microfluidic device with eight channel widths (0.80-3.00 m) in one field of view, we tracked unlabeled cells of eight species spanning five motility systems. Chamber height, a polymer additive and channel width each reordered the ranking. Vibrio alginolyticus, the fastest in open liquid, slowed to ~4 m/s in 1.25-m channels, whereas Campylobacter jejuni and Bacillus subtilis kept 33-46 m/s. Open liquid speed did not predict robustness to confinement. In two unrelated lineages, host symbionts that pass through narrow passages during colonization, Caballeronia insecticola and Vibrio fischeri, outran their non-symbiotic relatives in the channels, and crossed them with flagella wrapped around the cell body at nearly the speed of unwrapped cells. Where space is tight, the ability to keep moving, not top speed, sets the ranking.

microbiology↗
bioRxiv2026

The biochemical composition of coronavirus Nucleocapsid proteins drives the bicistronic properties of their sub-genomic mRNAs

The nucleocapsid (N) gene of coronaviruses (CoVs) encodes a structural RNA-binding protein required for viral assembly. In SARS- and MERS-CoV viruses, reading frame 2 of N contains an overlapping open reading frame (ORF) encoding an innate immune antagonist accessory protein. However, the extent of this dual coding capacity across the CoV family, and the genetic features driving overlapping ORF formation, remain unexamined. Here, we developed an in-silico tool (ORFan) to screen structural gene sub-genomic mRNA sequences from 152 species of coronavirus for the presence of overlapping accessory gene candidates. We found that frame 2 of the N gene in Alpha-, Beta- and Delta-CoVs frequently contains a potential accessory ORF (AcORF), conserved at the subgenus level, unlike the spike, envelope and membrane genes. We also show that CoV nucleotide biases in conjunction with codon biases integral to N protein function drive the relatively high abundances of start codons in frame two and stop codons in frame three, explaining the tendency towards frame 2 AcORFs. We further suggest that viral nucleotide biases and the codon composition required for RNA-binding function facilitate overlapping ORF formation in other virus families

microbiology↗
bioRxiv2026

Evaluating non-oxidative glycolysis using 13C metabolic flux analysis

Non-oxidative glycolysis (NOG) converts glucose to acetyl-CoA without emitting CO2 during Escherichia coli bioproduction. Although 13C-metabolic flux analysis (13C-MFA) has the potential to evaluate NOG flux distribution in vivo, the precision of these estimates depends on the labeling patterns of glucose tracers. Because E. coli has multiple native glycolysis pathways, selecting the optimal glucose tracer is important for precise estimates. This study used simulations to evaluate the performance of 18 commercially available glucose tracers in precisely predicting NOG flux. We artificially generated flux distributions of central metabolic pathways, including three types of NOG pathways, and obtained 13C labeling patterns of amino acids metabolized from each glucose tracer. Using these data, we then calculated 95% confidence intervals (CIs) for NOG pathway fluxes. Comparing the sum of CI widths from three NOG fluxes showed that estimation with [1,3-13C]-glucose yielded the narrowest CIs. Several tracers, including [2,3-13C]glucose, were capable of determining fluxes with high precision, but [1-13C]glucose was not one of them, despite often being used for estimating glycolytic fluxes. We then experimentally evaluated [2,3-13C]- and [1-13C]glucose as tracers in E. coli strains with and without the expression of phosphoketolase, which is required for NOG pathways to function. The results suggested that [1-13C]glucose could not detect NOG fluxes, whereas [2,3-13C]glucose estimated the fluxes of all three NOG pathways with narrow CIs.

microbiology↗